新闻稿

Illumina to Webcast Live Presentation at the J.P. Morgan Annual Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--Dec. 28, 2015-- Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company’s presentation at the J.P. Morgan 34th Annual Healthcare Conference in San Francisco, California, on January 11, 2016. The live webcast is scheduled to begin at 11:00 AM PT and will feature an overview of the company by Jay Flatley, Chief Executive Officer, followed by a question and answer session.

The webcast can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

 

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple, 858-882-6822
pr@illumina.com

 

近期文章

因美纳员工如何推动医疗保健向精准医学迈进
因美纳员工如何推动医疗保健向精准医学迈进
多组学助力区分疑难卵巢癌病例中的良性和恶性肿瘤
多组学助力区分疑难卵巢癌病例中的良性和恶性肿瘤
多组学技术赋能青年科研力量,加速科研源头创新与转化
多组学技术赋能青年科研力量,加速科研源头创新与转化